A new drug to potentially treat depression and neurodegenerative diseases, such as dementia or Parkinson’s, is being ...

In a mouse study, researchers found that zolpidem (Ambien), a common sleep aid, could prevent the brain from effectively ...

Nearly 7 million Americans have been diagnosed with dementia, which slowly erodes memory, thinking skills and the ability to ...

Cases of dementia in the U.S. are expected to steadily rise in the coming years, hitting 1 million annual cases by 2060.

The findings highlight the need for public-health strategies aimed at mitigating dementia risk and promoting healthy aging across diverse populations, researchers said. “I think ...

(“Alpha”) of the improved new drug ZUNVEYL（benzgalantamine delayed-release tablets）(“ZUNVEY” or the “Product”) for the treatment of mild-to-moderate dementia of the Alzheimer’s type. The Group is ...

A University of the Basque Country (UPV/EHU) study proves that the WIN55.212-2 drug protects the brain and reverses the ...

Cognitive profiles for early diagnosis of Dementia with Lewy bodies (DLB) have been outlined in a new study, out today in ...

“We are truly in a new era. We have opened the door to understanding ... based on a blood test as the enrolment criterion for dementia drug trials. That could pave the way for those blood ...

All 16 of Indiana’s designated senior care organizations — known as Area Agencies on Aging — are now required to have a ...

A simple digital health tool developed by Australian researchers could soon help predict the age of onset for early Alzheimer ...

said other states with similar programs have seen earlier detection and treatment, which can slow the progression of dementia. “This position can both provide consistency — this awareness and ...